Boston Scientific Expects Strong Gains in 2025: Time to Buy the Stock?

Boston Scientific Corporation (BSX) , despite industrywide macroeconomic upheavals,  has been seeing strong growth momentum across its target markets. Earlier this month, the company posted robust fourth-quarter 2024 results, surpassing market expectations and setting a positive outlook for 2025. These have led to upward revisions in analyst estimates.The Zacks Consensus Estimate for first-quarter 2025 earnings per share has been revised upward by 3 cents over the past 60 days, with six analysts upgrading t ...